Atlas Trials

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

Clinical trial NCT01514500 · COMPLETED

Trial details

NCT number
NCT01514500
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Growth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in ChildrenHealthy
Start date
2012-01-16
Primary completion
2013-03-18
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.